Jordana Joy

News|Articles|August 7, 2025 Exploratory analysis identifies predictors of improved BCVA in LHON Author(s) Jordana JoyNew research identifies key factors influencing visual recovery in Leber hereditary optic neuropathy patients treated with gene therapy, ... See more

News|Articles|August 29, 2025 Researchers examine brain immune cell impact on the eye Author(s) Jordana JoyResearchers used adaptive optics scanning light ophthalmoscopy (AOSLO) to study retinas in mice with photoreceptor damage, specifically photorecepto... See more

News|Articles|June 10, 2025 ZEISS fundus imaging device receives NMPA approval in China Author(s) Jordana JoyCLARUS 700, the advanced retinal imaging system, captures 133 degrees in a single image and up to 267 degrees with multiple images. Advertisement ... See more

The country currently has a goal of ensuring that more than 95% of patients with diabetes receive timely retinal examinations. Global artificial intelligence (AI) medical technology company Eyenuk has gotten the green light to deploy its EyeArt AI Eye Scr... See more

The lesion area growth was reduced by more than 50% in its first human clinical trial of K8. Inflammasome Therapeutics’ first inflammasome inhibitor, Kamuvudine, K8, was recently found to have reduced geographic atrophy (GA) lesion area growth by more tha... See more